Found: 53
Select item for more details and to access through your institution.
A computerized red glass test for quantifying diplopia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson's Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson's disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16747-6
- By:
- Publication type:
- Article
Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.851711
- By:
- Publication type:
- Article
Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
- Published in:
- Brain: A Journal of Neurology, 2022, v. 145, n. 12, p. 4448, doi. 10.1093/brain/awac084
- By:
- Publication type:
- Article
Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of statins on dopamine loss and prognosis in Parkinson's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reply: ARSA gene variants and Parkinson's disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effects of APOE4 on Alzheimer's disease, Lewy body disease, cerebral amyloid deposition and cognitive dysfunction: Neuropsychiatry and behavioral neurology/Dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.037300
- By:
- Publication type:
- Article
Effects of APOE4 on Alzheimer's disease, Lewy body disease, cerebral amyloid deposition and cognitive dysfunction: Neuropsychiatry and behavioral neurology/Dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037300
- By:
- Publication type:
- Article
Olfactory dysfunction in Alzheimer's disease– and Lewy body–related cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 10, p. 1243, doi. 10.1016/j.jalz.2018.05.010
- By:
- Publication type:
- Article
P3‐393: A NOMOGRAM FOR PREDICTING AMYLOID PET POSITIVITY IN AMNESTIC MILD COGNITIVE IMPAIRMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1248, doi. 10.1016/j.jalz.2018.06.1755
- By:
- Publication type:
- Article
O1‐13‐05: DISTINCT PATTERN OF CORTICAL ATROPHY IN ALZHEIMER'S DISEASE‐ AND LEWY BODY‐RELATED COGNITIVE IMPAIRMENT ACROSS THE DISEASE SPAN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P254, doi. 10.1016/j.jalz.2018.06.3045
- By:
- Publication type:
- Article
Implication of EEG theta/alpha and theta/beta ratio in Alzheimer's and Lewy body disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21951-5
- By:
- Publication type:
- Article
Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
- Published in:
- Human Brain Mapping, 2019, v. 40, n. 13, p. 3784, doi. 10.1002/hbm.24631
- By:
- Publication type:
- Article
OLFACTORY DYSFUNCTION IN ALZHEIMER- AND LEWY BODY-RELATED COGNITIVE IMPAIRMENT: DIAGNOSTIC IMPLICATION AND ASSOCIATION WITH COGNITION AND BRAIN ATROPHY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1524, doi. 10.1016/j.jalz.2017.07.654
- By:
- Publication type:
- Article
Structural connectivity networks in Alzheimer's disease and Lewy body disease.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 5, p. 1, doi. 10.1002/brb3.2112
- By:
- Publication type:
- Article
Patterns of Neuropsychological Profile and Cortical Thinning in Parkinson’s Disease with Punding.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0134468
- By:
- Publication type:
- Article
Diffusion tensor imaging‐based pontine damage as a degeneration marker in synucleinopathy.
- Published in:
- Journal of Neuroscience Research, 2021, v. 99, n. 11, p. 2922, doi. 10.1002/jnr.24926
- By:
- Publication type:
- Article
Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Distinct amyloid-dependent patterns of nigra dopamine depletion in Lewy body diseases.
- Published in:
- Frontiers in Aging Neuroscience, 2023, p. 01, doi. 10.3389/fnagi.2023.1196602
- By:
- Publication type:
- Article
Changes in plasma arylsulfatase A level as a compensatory biomarker of early Parkinson's disease.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62536-4
- By:
- Publication type:
- Article
Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson's disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47026-6
- By:
- Publication type:
- Article
Different effect of hypo- and hypermetabolism on cognition in dementia with Lewy bodies: are they coupled or independent?
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00622-w
- By:
- Publication type:
- Article
Urate is closely linked to white matter integrity in multiple system atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 6, p. 1029, doi. 10.1002/acn3.51073
- By:
- Publication type:
- Article
White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 2, p. 229, doi. 10.1002/acn3.50991
- By:
- Publication type:
- Article
Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 11, p. 2251, doi. 10.1002/acn3.50918
- By:
- Publication type:
- Article
Dopaminergic Depletion, β-Amyloid Burden, and Cognition in Lewy Body Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Inosine 5'‐Monophosphate to Raise Serum Uric Acid Level in Multiple System Atrophy (IMPROVE‐MSA study).
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 5, p. 1274, doi. 10.1002/cpt.2082
- By:
- Publication type:
- Article
Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 5213, doi. 10.1007/s00415-024-12477-z
- By:
- Publication type:
- Article
White matter connectivity networks predict levodopa-induced dyskinesia in Parkinson's disease.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 6, p. 2948, doi. 10.1007/s00415-021-10883-1
- By:
- Publication type:
- Article
Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson's disease.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 11, p. 4203, doi. 10.1007/s00415-021-10529-2
- By:
- Publication type:
- Article
Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 7, p. 1601, doi. 10.1007/s00415-019-09297-x
- By:
- Publication type:
- Article
Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93442-y
- By:
- Publication type:
- Article
Donepezil for mild cognitive impairment in Parkinson's disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84243-4
- By:
- Publication type:
- Article
Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 6, p. 1639, doi. 10.1111/ene.15781
- By:
- Publication type:
- Article
Association of cholesterol level with dopamine loss and motor deficits in Parkinson disease: A cross‐sectional study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 107, doi. 10.1111/ene.15592
- By:
- Publication type:
- Article
Neural correlates of self‐awareness of cognitive deficits in non‐demented patients with Parkinson's disease.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 12, p. 4022, doi. 10.1111/ene.15095
- By:
- Publication type:
- Article
Effects of Dihydropyridines on the Motor and Cognitive Outcomes of Patients with Parkinson's Disease.
- Published in:
- Movement Disorders, 2023, v. 38, n. 5, p. 843, doi. 10.1002/mds.29367
- By:
- Publication type:
- Article
White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 6, p. 1411, doi. 10.1002/mds.28510
- By:
- Publication type:
- Article
White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 6, p. 1411, doi. 10.1002/mds.28510
- By:
- Publication type:
- Article
Motor Cerebellar Connectivity and Future Development of Freezing of Gait in De Novo Parkinson's Disease.
- Published in:
- Movement Disorders, 2020, v. 35, n. 12, p. 2240, doi. 10.1002/mds.28243
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Erratum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12177
- By:
- Publication type:
- Article
Differential effects of cholesterol levels on cognition according to body mass index in Parkinson's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-023-01326-2
- By:
- Publication type:
- Article
Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 8, p. 1652, doi. 10.1007/s00259-019-04315-6
- By:
- Publication type:
- Article